A case of corneal opacity caused by atovaquone administration.

Purpose: Atovaquone is an alternative drug that is used for the prevention and treatment of pneumonia when the first-line drug, sulfamethoxazole-trimethoprim (ST combination), cannot be used due to side effects. However, atovaquone is known to cause ocular side effects including oculomucocutaneous syndrome and vortex keratopathy. In this report, we describe a patient who developed bilateral white granular diffuse corneal opacity that extended from the corneal sub-epithelium to the stroma after continuous oral atovaquone administration for 14 months.

Rational Synthesis of Highly Fluorescent N, S Co-Doped Carbon Dots Using Biogenic Creatinine for Cu Analysis in Drinking Water.

Herein, highly fluorescent sulfur and nitrogen co-doped carbon dots (N, S-CDs) had been employed as a fluorescent probe to analyze Cu in drinking water. The biogenic creatinine is known to form a stable complex with Cu; hence, it was rationally selected as a bioinspired nitrogen substrate for the first time to enhance N, S-CDs selectivity towards Cu. Moreover, the literature was surveyed to guide the selection of sulfur and carbon sources to optimize N, S-CDs quantum yield (QY), so thiourea and disodium edetate are co-carbonized with biogenic creatinine at 270°C for 40 min and characterized using different techniques.

The ability of diaphragmatic excursion after extubation to predict the need for resumption of ventilatory support in critically ill surgical patients.

Background: This study evaluated the ability of diaphragmatic excursion (DE), measured 2 h after extubation, to predict the need for resumption of ventilatory support within 48 h in surgical critically ill patients.

Methods: This prospective observational study included adult surgical critically ill patients intubated for > 24 h and extubated after a successful spontaneous breathing trial. Sonographic measurement of the DE was performed 2 h after extubation.

Evaluation of the antibacterial and antibiofilm effect of mycosynthesized silver and selenium nanoparticles and their synergistic effect with antibiotics on nosocomial bacteria.

Background: The healthcare sector faces a growing threat from the rise of highly resistant microorganisms, particularly Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa). Facing the challenge of antibiotic resistance, nanoparticles have surfaced as promising substitutes for antimicrobial therapy.